Value of apparent diffusion coefficient prior to neoadjuvant therapy is a predictor of histologic response in patients with borderline resectable pancreatic carcinoma

Okada Ken-ichi; Hirono Seiko; Kawai Manabu; Miyazawa Motoki; Shimizu Atsushi; Kitahata Yuji; Ueno Masaki; Hayami Shinya; Kojima Fumiyoshi; Yamaue Hiroki

首页> 外文期刊>Journal of hepato-biliary-pancreatic sciences >Value of apparent diffusion coefficient prior to neoadjuvant therapy is a predictor of histologic response in patients with borderline resectable pancreatic carcinoma

【24h】

Value of apparent diffusion coefficient prior to neoadjuvant therapy is a predictor of histologic response in patients with borderline resectable pancreatic carcinoma

机译：在Neoadjuvant疗法之前表观扩散系数的值是临界胰腺癌患者组织学反应的预测因子

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background The parameters to predict histological response to neoadjuvant therapy remain controversial in borderline resectable pancreatic carcinoma (BRPC).

机译：背景技术预测Neoadjuvant疗法的组织学响应的参数仍然存在涉及边缘可重置胰腺癌（BRPC）。

著录项

来源
《Journal of hepato-biliary-pancreatic sciences》 |2017年第3期|共8页
作者
Okada Ken-ichi; Hirono Seiko; Kawai Manabu; Miyazawa Motoki; Shimizu Atsushi; Kitahata Yuji; Ueno Masaki; Hayami Shinya; Kojima Fumiyoshi; Yamaue Hiroki;
展开▼
作者单位

Wakayama Med Univ Dept Surg 2 811-1 Kimiidera Wakayama 6418510 Japan;

Wakayama Med Univ Dept Surg 2 811-1 Kimiidera Wakayama 6418510 Japan;

Wakayama Med Univ Dept Surg 2 811-1 Kimiidera Wakayama 6418510 Japan;

Wakayama Med Univ Dept Surg 2 811-1 Kimiidera Wakayama 6418510 Japan;

Wakayama Med Univ Dept Surg 2 811-1 Kimiidera Wakayama 6418510 Japan;

Wakayama Med Univ Dept Surg 2 811-1 Kimiidera Wakayama 6418510 Japan;

Wakayama Med Univ Dept Surg 2 811-1 Kimiidera Wakayama 6418510 Japan;

Wakayama Med Univ Dept Surg 2 811-1 Kimiidera Wakayama 6418510 Japan;

Wakayama Med Univ Dept Human Pathol Wakayama Japan;

Wakayama Med Univ Dept Surg 2 811-1 Kimiidera Wakayama 6418510 Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类外科学;
关键词
Apparent diffusion coefficient; Borderline resectable; R0 curability;

机译：表观扩散系数;边界可重型;R0可固化性;

相似文献

外文文献
中文文献
专利

1. Value of apparent diffusion coefficient prior to neoadjuvant therapy is a predictor of histologic response in patients with borderline resectable pancreatic carcinoma [J] . Okada Ken-ichi, Hirono Seiko, Kawai Manabu, Journal of hepato-biliary-pancreatic sciences . 2017,第3期

机译：在Neoadjuvant疗法之前表观扩散系数的值是临界胰腺癌患者组织学反应的预测因子
2. Value of diffusion-weighted imaging for assessing site-specific response of advanced ovarian cancer to neoadjuvant chemotherapy: Correlation of apparent diffusion coefficients with epithelial and stromal densities on histology [J] . Stavroula Kyriazi, Emma Nye, Gordon Stamp, Cancer Biomarkers . 2010,第4a5期

机译：弥散加权成像在评估晚期卵巢癌对新辅助化疗的部位特异性反应中的价值：表观弥散系数与组织学上皮和基质密度的相关性
3. Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma [J] . Borhani Amir A., Dewan Rohit, Furlan Alessandro, AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences . 2020,第2期

机译：使用CT纹理分析在可重型和边缘可重置胰腺导管腺癌患者中使用CT纹理分析对Neoadjuvant治疗的反应评估
4. CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma [C] . Zhien Feng, Lizhen Wang, Bingshun Wang, Academic Committee Conference of Shanghai key lab of stomatology . 2011

机译：CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
5. Does pancreaticoduodenectomy with venous resection increase median survival when compared to palliative therapy in patients with borderline resectable pancreatic adenocarcinoma of the head of the pancreas? [D] . Lennon, Erin Frances 2010

机译：与颅底可重型胰腺腺癌患者的痛苦治疗相比，胰腺切除术治疗中位生存率是否增加了胰腺的头部胰腺炎的患者？
6. Sustained Carbohydrate Antigen 19‐9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and Survival [O] . J. Bart Rose, Alicia M. Edwards, Flavio G. Rocha, 2020

机译：持续的碳水化合物抗原19-9对边界可重症胰腺癌中新辅助化疗的反应预测进展和生存
7. Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy [O] . Eric A. Mellon, William H. Jin, Jessica M. Frakes, 2016

机译：临床切除和局部晚期胰腺癌病理肿瘤反应等级的预测因子和生存率，诱导化疗和新辅助立体定向体放射治疗

Value of apparent diffusion coefficient prior to neoadjuvant therapy is a predictor of histologic response in patients with borderline resectable pancreatic carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅